142 related articles for article (PubMed ID: 10364183)
1. Accelerated conversion of human plasminogen activator inhibitor-1 to its latent form by antibody binding.
Verhamme I; Kvassman JO; Day D; Debrock S; Vleugels N; Declerck PJ; Shore JD
J Biol Chem; 1999 Jun; 274(25):17511-7. PubMed ID: 10364183
[TBL] [Abstract][Full Text] [Related]
2. A fluorescent probe study of plasminogen activator inhibitor-1. Evidence for reactive center loop insertion and its role in the inhibitory mechanism.
Shore JD; Day DE; Francis-Chmura AM; Verhamme I; Kvassman J; Lawrence DA; Ginsburg D
J Biol Chem; 1995 Mar; 270(10):5395-8. PubMed ID: 7890653
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen activator inhibitor-1 is locked in active conformation and polymerizes upon binding ligands neutralizing its activity.
Jankun J; Specht Z; Szkudlarek M; Greenfield R; Gaikwad B; Trifonov L; Vaugeois J; Aleem AM; Basrur V; Selman SH; Zavodszky MI; Skrzypczak-Jankun E
Int J Mol Med; 2006 Mar; 17(3):437-47. PubMed ID: 16465390
[TBL] [Abstract][Full Text] [Related]
4. Additivity in effects of vitronectin and monoclonal antibodies against alpha-helix F of plasminogen activator inhibitor-1 on its reactions with target proteinases.
Komissarov AA; Andreasen PA; Bødker JS; Declerck PJ; Anagli JY; Shore JD
J Biol Chem; 2005 Jan; 280(2):1482-9. PubMed ID: 15516335
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory mechanism of serpins: loop insertion forces acylation of plasminogen activator by plasminogen activator inhibitor-1.
Kvassman JO; Verhamme I; Shore JD
Biochemistry; 1998 Nov; 37(44):15491-502. PubMed ID: 9799512
[TBL] [Abstract][Full Text] [Related]
6. Conformational changes of the reactive-centre loop and beta-strand 5A accompany temperature-dependent inhibitor-substrate transition of plasminogen-activator inhibitor 1.
Kjøller L; Martensen PM; Sottrup-Jensen L; Justesen J; Rodenburg KW; Andreasen PA
Eur J Biochem; 1996 Oct; 241(1):38-46. PubMed ID: 8898886
[TBL] [Abstract][Full Text] [Related]
7. Resolution of Michaelis complex, acylation, and conformational change steps in the reactions of the serpin, plasminogen activator inhibitor-1, with tissue plasminogen activator and trypsin.
Olson ST; Swanson R; Day D; Verhamme I; Kvassman J; Shore JD
Biochemistry; 2001 Oct; 40(39):11742-56. PubMed ID: 11570875
[TBL] [Abstract][Full Text] [Related]
8. Mapping of a conformational epitope on plasminogen activator inhibitor-1 by random mutagenesis. Implications for serpin function.
Gorlatova NV; Elokdah H; Fan K; Crandall DL; Lawrence DA
J Biol Chem; 2003 May; 278(18):16329-35. PubMed ID: 12606560
[TBL] [Abstract][Full Text] [Related]
9. Protonation state of a single histidine residue contributes significantly to the kinetics of the reaction of plasminogen activator inhibitor-1 with tissue-type plasminogen activator.
Komissarov AA; Declerck PJ; Shore JD
J Biol Chem; 2004 May; 279(22):23007-13. PubMed ID: 15033993
[TBL] [Abstract][Full Text] [Related]
10. A peptide mimicking the C-terminal part of the reactive center loop induces the transition to the latent form of plasminogen activator inhibitor type-1.
D'Amico S; Martial JA; Struman I
FEBS Lett; 2012 Mar; 586(6):686-92. PubMed ID: 22449964
[TBL] [Abstract][Full Text] [Related]
11. Type-1 plasminogen-activator inhibitor -- conformational differences between latent, active, reactive-centre-cleaved and plasminogen-activator-complexed forms, as probed by proteolytic susceptibility.
Egelund R; Schousboe SL; Sottrup-Jensen L; Rodenburg KW; Andreasen PA
Eur J Biochem; 1997 Sep; 248(3):775-85. PubMed ID: 9342229
[TBL] [Abstract][Full Text] [Related]
12. A peptide accelerating the conversion of plasminogen activator inhibitor-1 to an inactive latent state.
Mathiasen L; Dupont DM; Christensen A; Blouse GE; Jensen JK; Gils A; Declerck PJ; Wind T; Andreasen PA
Mol Pharmacol; 2008 Sep; 74(3):641-53. PubMed ID: 18559377
[TBL] [Abstract][Full Text] [Related]
13. The acid stabilization of plasminogen activator inhibitor-1 depends on protonation of a single group that affects loop insertion into beta-sheet A.
Kvassman JO; Lawrence DA; Shore JD
J Biol Chem; 1995 Nov; 270(46):27942-7. PubMed ID: 7499270
[TBL] [Abstract][Full Text] [Related]
14. Structural differences between active forms of plasminogen activator inhibitor type 1 revealed by conformationally sensitive ligands.
Li SH; Gorlatova NV; Lawrence DA; Schwartz BS
J Biol Chem; 2008 Jun; 283(26):18147-57. PubMed ID: 18436534
[TBL] [Abstract][Full Text] [Related]
15. Elucidation of the epitope of a latency-inducing antibody: identification of a new molecular target for PAI-1 inhibition.
Naessens D; Gils A; Compernolle G; Declerck PJ
Thromb Haemost; 2003 Jul; 90(1):52-8. PubMed ID: 12876625
[TBL] [Abstract][Full Text] [Related]
16. Evidence for a pre-latent form of the serpin plasminogen activator inhibitor-1 with a detached beta-strand 1C.
Dupont DM; Blouse GE; Hansen M; Mathiasen L; Kjelgaard S; Jensen JK; Christensen A; Gils A; Declerck PJ; Andreasen PA; Wind T
J Biol Chem; 2006 Nov; 281(47):36071-81. PubMed ID: 17018527
[TBL] [Abstract][Full Text] [Related]
17. Distinct encounter complexes of PAI-1 with plasminogen activators and vitronectin revealed by changes in the conformation and dynamics of the reactive center loop.
Qureshi T; Goswami S; McClintock CS; Ramsey MT; Peterson CB
Protein Sci; 2016 Feb; 25(2):499-510. PubMed ID: 26548921
[TBL] [Abstract][Full Text] [Related]
18. The reactive-center loop of active PAI-1 is folded close to the protein core and can be partially inserted.
Hägglöf P; Bergström F; Wilczynska M; Johansson LB; Ny T
J Mol Biol; 2004 Jan; 335(3):823-32. PubMed ID: 14687577
[TBL] [Abstract][Full Text] [Related]
19. The use of fluorescent probes to characterize conformational changes in the interaction between vitronectin and plasminogen activator inhibitor-1.
Gibson A; Baburaj K; Day DE; Verhamme I; Shore JD; Peterson CB
J Biol Chem; 1997 Feb; 272(8):5112-21. PubMed ID: 9030577
[TBL] [Abstract][Full Text] [Related]
20. Function-stabilizing mechanism of plasminogen activator inhibitor type 1 induced upon binding to alpha1-acid glycoprotein.
Smolarczyk K; Gils A; Boncela J; Declerck PJ; Cierniewski CS
Biochemistry; 2005 Sep; 44(37):12384-90. PubMed ID: 16156651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
